Healthcare Sector Stocks
The Healthcare sector has a total of 1064 stocks, with a combined market cap of $8.4 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 41.86.
Market Cap
8.4T
Revenue
4.52T
Profits
200.69B
PE Ratio
41.86
Profit Margin
4.44%
Dividend Yield
0.42%
1064 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 825.00B | -0.55% | 1,233,854 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 554.20B | -1.75% | 4,683,126 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 360.86B | -2.09% | 3,965,832 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 313.96B | -1.84% | 885,431 | 58.74B |
| 5 | UNH | UnitedHealth Group Incorporated | 293.77B | -0.30% | 6,628,181 | 447.57B |
| 6 | NVS | Novartis AG | 290.03B | -0.63% | 1,052,564 | 56.67B |
| 7 | MRK | Merck & Co., Inc. | 289.32B | -1.62% | 5,090,904 | 65.01B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 196.08B | 0.20% | 995,922 | 44.56B |
| 9 | AMGN | Amgen Inc. | 189.22B | -1.32% | 1,397,917 | 36.75B |
| 10 | NVO | Novo Nordisk A/S | 180.44B | 0.06% | 8,912,329 | 48.59B |
| 11 | GILD | Gilead Sciences, Inc. | 168.45B | -1.40% | 2,296,443 | 29.44B |
| 12 | ABT | Abbott Laboratories | 167.15B | -0.87% | 5,919,895 | 45.13B |
| 13 | ISRG | Intuitive Surgical, Inc. | 164.73B | -1.15% | 1,776,875 | 10.06B |
| 14 | PFE | Pfizer Inc. | 156.69B | -0.05% | 15,813,857 | 62.58B |
| 15 | DHR | Danaher Corporation | 138.21B | 0.28% | 3,607,130 | 24.57B |
| 16 | SYK | Stryker Corporation | 129.66B | -1.39% | 771,921 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 120.87B | -1.61% | 5,227,625 | 48.19B |
| 18 | SNY | Sanofi | 116.73B | -0.12% | 1,748,564 | 54.85B |
| 19 | GSK | GSK plc | 115.93B | -1.66% | 2,969,452 | 43.97B |
| 20 | VRTX | Vertex Pharmaceuticals Incorporated | 111.81B | -0.37% | 406,262 | 12.00B |
| 21 | MDT | Medtronic plc | 109.58B | -0.97% | 4,885,310 | 35.48B |
| 22 | HCA | HCA Healthcare, Inc. | 106.95B | -1.97% | 458,369 | 75.60B |
| 23 | MCK | McKesson Corporation | 104.94B | -1.11% | 393,590 | 397.96B |
| 24 | CVS | CVS Health Corporation | 98.12B | -0.96% | 4,954,184 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 90.40B | -5.29% | 12,950,211 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 76.91B | -0.15% | 339,791 | 14.34B |
| 27 | CI | The Cigna Group | 73.91B | 0.60% | 906,182 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 70.04B | -1.30% | 1,120,806 | 199.13B |
| 29 | MDLN | Medline Inc. | 63.28B | 1.11% | 2,853,163 | 28.43B |
| 30 | COR | Cencora, Inc. | 62.69B | -1.62% | 803,345 | 325.78B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 55.71B | -1.40% | 2,268,579 | 28.48B |
| 32 | ARGX | argenx SE | 52.70B | -1.36% | 151,019 | 4.24B |
| 33 | ZTS | Zoetis Inc. | 51.54B | 0.58% | 2,614,714 | 9.47B |
| 34 | CAH | Cardinal Health, Inc. | 49.70B | -1.29% | 978,707 | 244.67B |
| 35 | EW | Edwards Lifesciences Corporation | 47.14B | 0.95% | 4,023,933 | 6.07B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 46.24B | -1.21% | 428,867 | 4.30B |
| 37 | BDX | Becton, Dickinson and Company | 45.07B | -0.15% | 2,296,310 | 21.92B |
| 38 | HLN | Haleon plc | 43.30B | -0.67% | 4,153,154 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.13B | 0.15% | 547,211 | 3.71B |
| 40 | ALC | Alcon Inc. | 39.96B | -1.39% | 616,070 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 37.32B | -1.08% | 2,111,949 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 35.43B | -1.35% | 99,106 | 5.34B |
| 43 | A | Agilent Technologies, Inc. | 34.11B | -0.96% | 814,521 | 7.07B |
| 44 | GEHC | GE HealthCare Technologies Inc. | 33.83B | -0.70% | 1,498,453 | 20.63B |
| 45 | WAT | Waters Corporation | 32.90B | 2.26% | 459,394 | 3.17B |
| 46 | RMD | ResMed Inc. | 32.74B | -1.06% | 527,635 | 5.40B |
| 47 | RVMD | Revolution Medicines, Inc. | 31.11B | -0.49% | 2,309,297 | - |
| 48 | INSM | Insmed Incorporated | 30.85B | -1.07% | 723,287 | 606.42M |
| 49 | IQV | IQVIA Holdings Inc. | 29.64B | 0.06% | 697,835 | 16.31B |
| 50 | NTRA | Natera, Inc. | 29.38B | -0.53% | 596,178 | 2.31B |
| 51 | RPRX | Royalty Pharma plc | 29.23B | -1.38% | 1,702,957 | 2.38B |
| 52 | PHG | Koninklijke Philips N.V. | 27.82B | -1.84% | 590,727 | 20.94B |
| 53 | VEEV | Veeva Systems Inc. | 27.64B | 0.75% | 1,227,820 | 3.20B |
| 54 | BIIB | Biogen Inc. | 26.92B | 3.44% | 1,002,774 | 9.89B |
| 55 | MTD | Mettler-Toledo International Inc. | 26.79B | -1.30% | 75,665 | 4.03B |
| 56 | BNTX | BioNTech SE | 26.50B | 1.82% | 695,524 | 3.37B |
| 57 | HUM | Humana Inc. | 25.25B | 2.54% | 1,173,688 | 129.66B |
| 58 | UTHR | United Therapeutics Corporation | 25.16B | -2.45% | 261,504 | 3.18B |
| 59 | DXCM | DexCom, Inc. | 24.99B | 1.23% | 2,137,222 | 4.66B |
| 60 | LH | Labcorp Holdings Inc. | 22.10B | -0.68% | 361,561 | 13.95B |
| 61 | STE | STERIS plc | 22.08B | -0.31% | 298,733 | 5.83B |
| 62 | DGX | Quest Diagnostics Incorporated | 21.71B | 0.59% | 1,380,162 | 11.04B |
| 63 | MRNA | Moderna, Inc. | 21.57B | 1.27% | 4,474,080 | 1.94B |
| 64 | ROIV | Roivant Sciences Ltd. | 20.85B | -2.35% | 3,415,771 | 13.31M |
| 65 | ILMN | Illumina, Inc. | 20.22B | -1.03% | 597,876 | 4.34B |
| 66 | WST | West Pharmaceutical Services, Inc. | 19.94B | 1.15% | 652,788 | 3.07B |
| 67 | SMMT | Summit Therapeutics Inc. | 19.59B | 0.48% | 2,572,210 | - |
| 68 | INCY | Incyte Corporation | 19.34B | -0.67% | 698,012 | 5.14B |
| 69 | CNC | Centene Corporation | 18.81B | 0.18% | 2,063,268 | 176.15B |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 18.46B | 0.61% | 1,150,988 | 8.23B |
| 71 | GMAB | Genmab A/S | 17.49B | -2.17% | 1,670,985 | 3.72B |
| 72 | VTRS | Viatris Inc. | 17.29B | 1.16% | 8,971,878 | 14.30B |
| 73 | THC | Tenet Healthcare Corporation | 16.65B | -2.64% | 971,854 | 21.31B |
| 74 | ASND | Ascendis Pharma A/S | 15.27B | 0.36% | 312,574 | 845.52M |
| 75 | MEDP | Medpace Holdings, Inc. | 15.09B | 1.49% | 255,452 | 2.53B |
| 76 | BBIO | BridgeBio Pharma, Inc. | 14.82B | -0.38% | 1,250,914 | 502.08M |
| 77 | SNN | Smith & Nephew plc | 14.68B | -0.67% | 868,091 | 6.16B |
| 78 | PODD | Insulet Corporation | 13.92B | -1.38% | 397,720 | 2.71B |
| 79 | RGC | Regencell Bioscience Holdings Limited | 13.89B | -2.06% | 69,454 | - |
| 80 | ALGN | Align Technology, Inc. | 13.75B | 1.00% | 422,857 | 4.03B |
| 81 | COO | The Cooper Companies, Inc. | 13.54B | -0.91% | 860,602 | 4.15B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | 13.22B | -1.11% | 1,404,666 | 2.86B |
| 83 | GMED | Globus Medical, Inc. | 13.08B | 1.54% | 626,024 | 2.94B |
| 84 | PEN | Penumbra, Inc. | 12.95B | -0.83% | 285,259 | 1.40B |
| 85 | FMS | Fresenius Medical Care AG | 12.53B | -1.05% | 577,505 | 23.05B |
| 86 | JAZZ | Jazz Pharmaceuticals plc | 12.48B | -0.36% | 585,485 | 4.27B |
| 87 | IONS | Ionis Pharmaceuticals, Inc. | 12.38B | -1.00% | 711,852 | 943.71M |
| 88 | SOLV | Solventum Corporation | 12.14B | -0.65% | 576,076 | 8.33B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.07B | -1.08% | 149,486 | 958.40M |
| 90 | GH | Guardant Health, Inc. | 11.88B | 0.27% | 1,711,573 | 982.02M |
| 91 | ELAN | Elanco Animal Health Incorporated | 11.77B | -0.46% | 1,097,482 | 4.72B |
| 92 | ENSG | The Ensign Group, Inc. | 11.54B | -1.25% | 160,236 | 5.06B |
| 93 | EXEL | Exelixis, Inc. | 11.34B | -2.74% | 1,376,411 | 2.32B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.03B | -1.54% | 1,326,437 | 3.85B |
| 95 | UHS | Universal Health Services, Inc. | 10.97B | -1.49% | 434,859 | 17.36B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 10.58B | 0.68% | 1,073,656 | 3.22B |
| 97 | EHC | Encompass Health Corporation | 10.58B | 0.01% | 393,219 | 5.94B |
| 98 | RVTY | Revvity, Inc. | 10.40B | -1.02% | 444,611 | 2.86B |
| 99 | TEM | Tempus AI, Inc. | 10.20B | 1.92% | 5,192,352 | 1.27B |
| 100 | DVA | DaVita Inc. | 9.98B | 1.01% | 288,303 | 13.64B |
| 101 | BTSG | BrightSpring Health Services, Inc. | 9.77B | 0.85% | 770,815 | 12.91B |
| 102 | BAX | Baxter International Inc. | 9.74B | 0.80% | 4,910,842 | 11.24B |
| 103 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.72B | -0.12% | 785,155 | 1.09B |
| 104 | AXSM | Axsome Therapeutics, Inc. | 9.68B | 0.08% | 397,727 | 638.50M |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 9.56B | 0.18% | 283,595 | 7.46M |
| 106 | TECH | Bio-Techne Corporation | 9.52B | 2.74% | 1,425,381 | 1.22B |
| 107 | ABVX | ABIVAX Société Anonyme | 9.39B | -3.60% | 717,056 | 5.37M |
| 108 | MASI | Masimo Corporation | 9.31B | 0.01% | 441,704 | 1.53B |
| 109 | CRL | Charles River Laboratories International, Inc. | 9.14B | 0.73% | 378,228 | 4.02B |
| 110 | HSIC | Henry Schein, Inc. | 9.06B | 0.16% | 870,017 | 13.18B |
| 111 | ICLR | ICON Public Limited Company | 8.96B | -1.94% | 824,929 | 8.10B |
| 112 | PCVX | Vaxcyte, Inc. | 8.94B | -0.40% | 667,192 | - |
| 113 | NUVL | Nuvalent, Inc. | 8.54B | 0.95% | 291,837 | - |
| 114 | IBRX | ImmunityBio, Inc. | 8.49B | 6.75% | 15,143,292 | 113.29M |
| 115 | QGEN | Qiagen N.V. | 8.48B | -0.56% | 808,806 | 2.09B |
| 116 | ATR | AptarGroup, Inc. | 8.33B | - | 183,753 | 3.78B |
| 117 | HALO | Halozyme Therapeutics, Inc. | 8.27B | 0.72% | 659,053 | 1.40B |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 8.21B | 1.75% | 105,831 | 2.58B |
| 119 | KRYS | Krystal Biotech, Inc. | 8.19B | 1.45% | 154,069 | 389.13M |
| 120 | CYTK | Cytokinetics, Incorporated | 8.14B | -0.91% | 670,746 | 88.04M |
| 121 | MOH | Molina Healthcare, Inc. | 7.84B | 0.98% | 617,863 | 43.56B |
| 122 | RGEN | Repligen Corporation | 7.44B | 0.50% | 495,325 | 738.26M |
| 123 | HQY | HealthEquity, Inc. | 7.30B | 0.48% | 568,412 | 1.31B |
| 124 | GKOS | Glaukos Corporation | 7.19B | -0.75% | 290,480 | 507.44M |
| 125 | KYMR | Kymera Therapeutics, Inc. | 7.14B | -0.26% | 216,105 | 39.21M |
| 126 | HIMS | Hims & Hers Health, Inc. | 7.12B | 8.40% | 63,589,162 | 2.35B |
| 127 | GRFS | Grifols, S.A. | 7.07B | -3.26% | 247,010 | 8.83B |
| 128 | APGE | Apogee Therapeutics, Inc. | 6.79B | -0.24% | 297,523 | - |
| 129 | ACLX | Arcellx, Inc. | 6.75B | -0.04% | 617,837 | 22.29M |
| 130 | ERAS | Erasca, Inc. | 6.71B | 13.65% | 5,641,388 | - |
| 131 | PTGX | Protagonist Therapeutics, Inc. | 6.71B | -0.76% | 253,819 | 46.02M |
| 132 | BLTE | Belite Bio, Inc | 6.48B | -0.40% | 60,891 | - |
| 133 | SYRE | Spyre Therapeutics, Inc. | 6.35B | 0.79% | 616,021 | - |
| 134 | BRKR | Bruker Corporation | 6.26B | 1.01% | 2,325,138 | 3.44B |
| 135 | CNTA | Centessa Pharmaceuticals plc | 6.11B | -0.32% | 1,534,393 | 15.00M |
| 136 | TERN | Terns Pharmaceuticals, Inc. | 6.09B | 0.12% | 2,998,616 | - |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.03B | -0.46% | 418,346 | 189.76M |
| 138 | CAI | Caris Life Sciences, Inc. | 6.02B | 0.76% | 1,007,431 | 812.03M |
| 139 | CGON | CG Oncology, Inc. | 6.00B | -3.23% | 654,558 | 4.04M |
| 140 | PTCT | PTC Therapeutics, Inc. | 5.98B | -0.23% | 328,559 | 1.73B |
| 141 | COGT | Cogent Biosciences, Inc. | 5.97B | -0.43% | 828,354 | - |
| 142 | BLCO | Bausch + Lomb Corporation | 5.95B | -0.71% | 150,856 | 5.10B |
| 143 | TFX | Teleflex Incorporated | 5.84B | 0.34% | 635,616 | 1.99B |
| 144 | CELC | Celcuity Inc. | 5.84B | -1.32% | 317,091 | - |
| 145 | IMVT | Immunovant, Inc. | 5.81B | -2.56% | 1,244,222 | - |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 5.77B | -2.46% | 262,930 | 521.31M |
| 147 | AVTR | Avantor, Inc. | 5.76B | 0.06% | 8,446,065 | 6.55B |
| 148 | ALKS | Alkermes plc | 5.67B | -1.16% | 710,228 | 1.48B |
| 149 | PACS | PACS Group, Inc. | 5.65B | 2.13% | 697,627 | 5.29B |
| 150 | CRSP | CRISPR Therapeutics AG | 5.56B | -0.16% | 815,750 | 3.51M |
| 151 | SRRK | Scholar Rock Holding Corporation | 5.50B | -4.12% | 743,116 | - |
| 152 | XENE | Xenon Pharmaceuticals Inc. | 5.46B | -4.10% | 745,783 | 7.50M |
| 153 | TGTX | TG Therapeutics, Inc. | 5.45B | 4.42% | 2,025,150 | 616.29M |
| 154 | LNTH | Lantheus Holdings, Inc. | 5.44B | -0.10% | 355,819 | 1.54B |
| 155 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | 0.02% | 3,079,122 | 1.00B |
| 156 | CHE | Chemed Corporation | 5.20B | 0.75% | 137,242 | 2.53B |
| 157 | WAY | Waystar Holding Corp. | 5.10B | 3.14% | 993,498 | 1.10B |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 5.05B | -0.56% | 393,701 | 2.04M |
| 159 | CORT | Corcept Therapeutics Incorporated | 4.95B | 0.91% | 509,377 | 761.41M |
| 160 | OSCR | Oscar Health, Inc. | 4.88B | 3.89% | 4,814,289 | 11.70B |
| 161 | SHC | Sotera Health Company | 4.64B | -0.21% | 1,413,554 | 1.16B |
| 162 | LGND | Ligand Pharmaceuticals Incorporated | 4.63B | 0.06% | 81,568 | 268.09M |
| 163 | LEGN | Legend Biotech Corporation | 4.62B | 17.95% | 6,270,000 | 1.03B |
| 164 | FOLD | Amicus Therapeutics, Inc. | 4.54B | -0.03% | 1,102,427 | 634.21M |
| 165 | NVST | Envista Holdings Corporation | 4.53B | -0.16% | 1,333,831 | 2.72B |
| 166 | OPCH | Option Care Health, Inc. | 4.51B | -0.35% | 561,163 | 5.65B |
| 167 | RDNT | RadNet, Inc. | 4.49B | -4.29% | 789,438 | 2.04B |
| 168 | DOCS | Doximity, Inc. | 4.48B | -1.86% | 2,705,291 | 637.78M |
| 169 | ALHC | Alignment Healthcare, Inc. | 4.39B | 1.27% | 1,543,193 | 3.95B |
| 170 | STVN | Stevanato Group S.p.A. | 4.36B | 2.74% | 223,366 | 1.39B |
| 171 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.21B | -1.83% | 426,523 | 7.70M |
| 172 | AMRX | Amneal Pharmaceuticals, Inc. | 4.21B | -5.10% | 976,204 | 3.02B |
| 173 | MMSI | Merit Medical Systems, Inc. | 4.17B | -1.33% | 298,449 | 1.52B |
| 174 | VKTX | Viking Therapeutics, Inc. | 4.13B | 1.16% | 1,499,829 | - |
| 175 | IRTC | iRhythm Holdings, Inc. | 4.02B | -0.79% | 217,058 | 747.14M |
| 176 | BLLN | BillionToOne, Inc. | 3.94B | 7.83% | 699,475 | 305.11M |
| 177 | NAMS | NewAmsterdam Pharma Company N.V. | 3.90B | -2.31% | 320,075 | 22.50M |
| 178 | TMDX | TransMedics Group, Inc. | 3.90B | -2.68% | 564,778 | 605.49M |
| 179 | MMED | MiniMed Group, Inc. | 3.84B | -5.33% | 381,742 | 2.99B |
| 180 | TWST | Twist Bioscience Corporation | 3.79B | 3.28% | 763,019 | 391.56M |
| 181 | TNGX | Tango Therapeutics, Inc. | 3.78B | -0.68% | 1,089,086 | 62.38M |
| 182 | ACAD | ACADIA Pharmaceuticals Inc. | 3.75B | -0.77% | 671,020 | 1.07B |
| 183 | TVTX | Travere Therapeutics, Inc. | 3.71B | -1.47% | 1,120,488 | 490.73M |
| 184 | EWTX | Edgewise Therapeutics, Inc. | 3.65B | -1.25% | 447,242 | - |
| 185 | LIVN | LivaNova PLC | 3.60B | -1.92% | 514,714 | 1.39B |
| 186 | TLX | Telix Pharmaceuticals Limited | 3.60B | -0.09% | 136,381 | 803.79M |
| 187 | ORKA | Oruka Therapeutics, Inc. | 3.43B | 0.44% | 1,078,350 | - |
| 188 | GPCR | Structure Therapeutics Inc. | 3.41B | -5.27% | 540,687 | - |
| 189 | HNGE | Hinge Health, Inc. | 3.37B | 0.62% | 423,416 | 587.86M |
| 190 | LQDA | Liquidia Corporation | 3.33B | -4.21% | 1,225,831 | 158.32M |
| 191 | DYN | Dyne Therapeutics, Inc. | 3.32B | -1.59% | 1,336,256 | - |
| 192 | ICUI | ICU Medical, Inc. | 3.28B | 0.91% | 140,237 | 2.23B |
| 193 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.28B | -4.63% | 909,288 | 677.56M |
| 194 | DNLI | Denali Therapeutics Inc. | 3.26B | -0.19% | 490,538 | - |
| 195 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.20B | -0.11% | 1,195,153 | 588.99M |
| 196 | BKD | Brookdale Senior Living Inc. | 3.20B | -2.18% | 2,715,627 | 3.05B |
| 197 | KLRA | Kailera Therapeutics, Inc. | 3.19B | -0.73% | 1,122,844 | - |
| 198 | ALMS | Alumis Inc. | 3.17B | -0.12% | 529,952 | 24.05M |
| 199 | TXG | 10x Genomics, Inc. | 3.17B | -4.87% | 2,875,203 | 642.82M |
| 200 | WRBY | Warby Parker Inc. | 3.13B | 2.94% | 2,757,112 | 871.91M |
| 201 | BEAM | Beam Therapeutics Inc. | 3.11B | -0.13% | 873,091 | 139.74M |
| 202 | ITGR | Integer Holdings Corporation | 3.04B | -0.94% | 138,392 | 1.85B |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.04B | -0.24% | 454,385 | 376.07M |
| 204 | PRVA | Privia Health Group, Inc. | 3.02B | 0.12% | 252,574 | 2.12B |
| 205 | VERA | Vera Therapeutics, Inc. | 2.99B | -1.37% | 477,999 | - |
| 206 | IDYA | IDEAYA Biosciences, Inc. | 2.96B | -0.50% | 579,180 | 218.71M |
| 207 | RLAY | Relay Therapeutics, Inc. | 2.94B | -1.91% | 1,990,879 | 15.36M |
| 208 | SUPN | Supernus Pharmaceuticals, Inc. | 2.94B | -0.72% | 286,450 | 718.95M |
| 209 | CON | Concentra Group Holdings Parent, Inc. | 2.94B | -0.04% | 172,321 | 2.16B |
| 210 | RCUS | Arcus Biosciences, Inc. | 2.88B | -5.28% | 1,461,589 | 247.00M |
| 211 | NKTR | Nektar Therapeutics | 2.87B | 17.84% | 4,392,646 | 55.23M |
| 212 | KOD | Kodiak Sciences Inc. | 2.86B | 3.23% | 552,314 | - |
| 213 | ZLAB | Zai Lab Limited | 2.84B | 4.26% | 709,756 | 460.16M |
| 214 | HAE | Haemonetics Corporation | 2.84B | -0.94% | 361,812 | 1.32B |
| 215 | TARS | Tarsus Pharmaceuticals, Inc. | 2.80B | -2.02% | 316,162 | 451.36M |
| 216 | ELVN | Enliven Therapeutics, Inc. | 2.79B | -3.14% | 375,084 | - |
| 217 | PBH | Prestige Consumer Healthcare Inc. | 2.77B | 0.76% | 181,318 | 1.10B |
| 218 | IMNM | Immunome, Inc. | 2.75B | -1.34% | 384,068 | 6.94M |
| 219 | MANE | Veradermics, Incorporated | 2.75B | -3.55% | 214,775 | - |
| 220 | IRON | Disc Medicine, Inc. | 2.74B | 0.08% | 126,112 | - |
| 221 | SLNO | Soleno Therapeutics, Inc. | 2.72B | -0.19% | 2,393,469 | 190.41M |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.71B | -0.17% | 658,643 | 1.55M |
| 223 | LFST | LifeStance Health Group, Inc. | 2.70B | 0.58% | 1,031,521 | 1.42B |
| 224 | HTFL | HeartFlow, Inc. | 2.69B | 0.19% | 776,903 | 176.03M |
| 225 | VCYT | Veracyte, Inc. | 2.66B | -0.89% | 251,397 | 517.15M |
| 226 | LMAT | LeMaitre Vascular, Inc. | 2.62B | 0.45% | 107,953 | 249.60M |
| 227 | NHC | National HealthCare Corporation | 2.61B | -0.44% | 68,845 | 1.52B |
| 228 | ADMA | ADMA Biologics, Inc. | 2.60B | -1.00% | 3,469,793 | 510.17M |
| 229 | XRAY | DENTSPLY SIRONA Inc. | 2.56B | 2.72% | 3,924,733 | 3.68B |
| 230 | HCM | HUTCHMED (China) Limited | 2.56B | -0.32% | 67,232 | 548.51M |
| 231 | ACHC | Acadia Healthcare Company, Inc. | 2.56B | 3.02% | 2,778,947 | 3.31B |
| 232 | MLYS | Mineralys Therapeutics, Inc. | 2.48B | -1.70% | 435,265 | - |
| 233 | RARE | Ultragenyx Pharmaceutical Inc. | 2.46B | 1.13% | 1,085,003 | 673.00M |
| 234 | OGN | Organon & Co. | 2.42B | -4.61% | 5,738,898 | 6.22B |
| 235 | AAPG | Ascentage Pharma Group International | 2.42B | -1.46% | 1,772 | 82.08M |
| 236 | GRDN | Guardian Pharmacy Services, Inc. | 2.36B | -0.56% | 210,470 | 1.45B |
| 237 | DFTX | Definium Therapeutics, Inc. | 2.32B | 2.47% | 5,279,091 | - |
| 238 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.29B | -3.84% | 2,254,968 | 874.84M |
| 239 | PAHC | Phibro Animal Health Corporation | 2.29B | -1.00% | 74,381 | 1.46B |
| 240 | ADPT | Adaptive Biotechnologies Corporation | 2.24B | 0.69% | 1,070,112 | 276.98M |
| 241 | SRPT | Sarepta Therapeutics, Inc. | 2.24B | -1.16% | 2,020,684 | 2.20B |
| 242 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.05% | 1,081,964 | 158.18M |
| 243 | BHC | Bausch Health Companies Inc. | 2.21B | 0.51% | 829,391 | 10.27B |
| 244 | TRVI | Trevi Therapeutics, Inc. | 2.17B | 1.84% | 2,641,439 | - |
| 245 | STOK | Stoke Therapeutics, Inc. | 2.15B | -2.39% | 300,494 | 184.42M |
| 246 | MESO | Mesoblast Limited | 2.13B | 1.46% | 201,796 | 65.38M |
| 247 | AUPH | Aurinia Pharmaceuticals Inc. | 2.12B | -0.53% | 608,731 | 283.06M |
| 248 | SNDX | Syndax Pharmaceuticals, Inc. | 2.11B | -1.44% | 537,492 | 172.35M |
| 249 | GRAL | GRAIL, Inc. | 2.10B | -0.96% | 223,430 | 147.17M |
| 250 | NEOG | Neogen Corporation | 2.09B | 1.16% | 873,570 | 870.56M |
| 251 | OCUL | Ocular Therapeutix, Inc. | 2.08B | -2.60% | 2,482,710 | 51.95M |
| 252 | ZYME | Zymeworks Inc. | 2.05B | 0.22% | 207,147 | 105.97M |
| 253 | WGS | GeneDx Holdings Corp. | 2.05B | 6.12% | 494,592 | 427.54M |
| 254 | SEM | Select Medical Holdings Corporation | 2.04B | 0.18% | 805,275 | 5.45B |
| 255 | CAPR | Capricor Therapeutics, Inc. | 1.98B | -1.33% | 780,330 | 11.13M |
| 256 | ESTA | Establishment Labs Holdings Inc. | 1.97B | -0.19% | 256,526 | 211.08M |
| 257 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.95B | -3.98% | 597,829 | -665.00K |
| 258 | RXRX | Recursion Pharmaceuticals, Inc. | 1.95B | -2.51% | 8,222,330 | 74.68M |
| 259 | SION | Sionna Therapeutics, Inc. | 1.94B | -0.99% | 304,907 | - |
| 260 | AXGN | Axogen, Inc. | 1.93B | -3.51% | 375,820 | 225.21M |
| 261 | GLPG | Galapagos NV | 1.92B | 0.20% | 51,663 | 1.31B |
| 262 | PHVS | Pharvaris N.V. | 1.90B | 1.49% | 127,791 | - |
| 263 | MD | Pediatrix Medical Group, Inc. | 1.88B | 0.56% | 296,663 | 1.91B |
| 264 | AORT | Artivion, Inc. | 1.87B | 2.47% | 260,751 | 441.33M |
| 265 | TYRA | Tyra Biosciences, Inc. | 1.87B | -2.33% | 961,981 | - |
| 266 | ANIP | ANI Pharmaceuticals, Inc. | 1.86B | 0.93% | 174,377 | 883.37M |
| 267 | TSHA | Taysha Gene Therapies, Inc. | 1.85B | 0.31% | 2,158,050 | 9.77M |
| 268 | PVLA | Palvella Therapeutics, Inc. | 1.85B | -0.50% | 134,154 | - |
| 269 | SGRY | Surgery Partners, Inc. | 1.83B | 2.14% | 488,385 | 3.31B |
| 270 | VCEL | Vericel Corporation | 1.82B | 0.41% | 349,740 | 276.26M |
| 271 | NTLA | Intellia Therapeutics, Inc. | 1.81B | 2.27% | 2,023,106 | 67.67M |
| 272 | ATAI | AtaiBeckley Inc. | 1.80B | 22.58% | 44,735,217 | 4.09M |
| 273 | RAPP | Rapport Therapeutics, Inc. | 1.79B | -5.74% | 157,243 | - |
| 274 | VIR | Vir Biotechnology, Inc. | 1.78B | 3.81% | 2,333,123 | 68.56M |
| 275 | NUVB | Nuvation Bio Inc. | 1.77B | 0.30% | 2,941,368 | 62.90M |
| 276 | INVA | Innoviva, Inc. | 1.77B | -1.44% | 327,691 | 411.33M |
| 277 | NRIX | Nurix Therapeutics, Inc. | 1.77B | -2.51% | 423,978 | 71.78M |
| 278 | ATEC | Alphatec Holdings, Inc. | 1.73B | 2.88% | 1,766,379 | 764.16M |
| 279 | AHCO | AdaptHealth Corp. | 1.72B | 0.24% | 647,093 | 3.24B |
| 280 | OMCL | Omnicell, Inc. | 1.71B | -1.57% | 522,673 | 1.18B |
| 281 | HRMY | Harmony Biosciences Holdings, Inc. | 1.71B | -1.67% | 568,813 | 868.45M |
| 282 | ADUS | Addus HomeCare Corporation | 1.70B | -0.58% | 85,704 | 1.42B |
| 283 | OCS | Oculis Holding AG | 1.69B | 3.79% | 532,723 | 1.51M |
| 284 | PRGO | Perrigo Company plc | 1.66B | 2.16% | 1,262,759 | 4.25B |
| 285 | INSP | Inspire Medical Systems, Inc. | 1.63B | -1.56% | 449,711 | 911.98M |
| 286 | BHVN | Biohaven Ltd. | 1.63B | -1.28% | 1,064,525 | - |
| 287 | AHG | Akso Health Group | 1.63B | -5.00% | 191,974 | 14.84M |
| 288 | SNDA | Sonida Senior Living, Inc. | 1.61B | -0.55% | 403,465 | 336.39M |
| 289 | MBX | MBX Biosciences, Inc. | 1.61B | 0.30% | 374,912 | - |
| 290 | PLSE | Pulse Biosciences, Inc. | 1.61B | 0.90% | 194,705 | 350.00K |
| 291 | IMCR | Immunocore Holdings plc | 1.60B | 0.06% | 549,227 | 400.02M |
| 292 | DMRA | Damora Therapeutics, Inc. | 1.59B | -0.64% | 158,957 | - |
| 293 | GLUE | Monte Rosa Therapeutics, Inc. | 1.59B | 0.68% | 634,266 | 123.67M |
| 294 | NBTX | Nanobiotix S.A. | 1.59B | -5.86% | 78,340 | 38.27M |
| 295 | AGIO | Agios Pharmaceuticals, Inc. | 1.58B | -23.31% | 5,207,275 | 54.03M |
| 296 | IOVA | Iovance Biotherapeutics, Inc. | 1.57B | -1.55% | 8,876,861 | 263.50M |
| 297 | ASTH | Astrana Health, Inc. | 1.56B | 0.13% | 469,487 | 3.18B |
| 298 | GENB | Generate Biomedicines, Inc. | 1.55B | -2.09% | 328,739 | 31.89M |
| 299 | BCAX | Bicara Therapeutics Inc. | 1.55B | -1.58% | 242,173 | - |
| 300 | ARDX | Ardelyx, Inc. | 1.54B | -2.71% | 2,239,708 | 407.32M |
| 301 | UFPT | UFP Technologies, Inc. | 1.54B | -1.61% | 129,560 | 602.80M |
| 302 | ENOV | Enovis Corporation | 1.52B | 0.46% | 339,748 | 2.25B |
| 303 | HROW | Harrow, Inc. | 1.51B | -2.27% | 383,565 | 272.30M |
| 304 | IMTX | Immatics N.V. | 1.51B | 0.72% | 201,719 | 56.67M |
| 305 | VRDN | Viridian Therapeutics, Inc. | 1.50B | -0.68% | 1,125,169 | 70.85M |
| 306 | AVAH | Aveanna Healthcare Holdings Inc. | 1.49B | 1.03% | 1,265,396 | 2.43B |
| 307 | ALMR | Alamar Biosciences, Inc. | 1.47B | 0.23% | 906,908 | 74.21M |
| 308 | ANAB | AnaptysBio, Inc. | 1.47B | -24.50% | 885,116 | 234.60M |
| 309 | PGEN | Precigen, Inc. | 1.46B | 3.64% | 3,148,346 | 9.68M |
| 310 | TNDM | Tandem Diabetes Care, Inc. | 1.46B | 3.30% | 1,356,815 | 1.01B |
| 311 | ARDT | Ardent Health, Inc. | 1.46B | 2.72% | 286,130 | 6.32B |
| 312 | PGNY | Progyny, Inc. | 1.45B | 2.43% | 700,470 | 1.29B |
| 313 | PRCT | PROCEPT BioRobotics Corporation | 1.45B | 2.15% | 599,410 | 308.05M |
| 314 | NVCR | NovoCure Limited | 1.45B | -0.86% | 600,259 | 655.35M |
| 315 | OLMA | Olema Pharmaceuticals, Inc. | 1.44B | -1.55% | 693,526 | - |
| 316 | ATRC | AtriCure, Inc. | 1.44B | -4.41% | 1,048,777 | 534.53M |
| 317 | SVRA | Savara Inc. | 1.43B | -2.42% | 599,896 | - |
| 318 | WVE | Wave Life Sciences Ltd. | 1.42B | 0.93% | 2,831,463 | 42.73M |
| 319 | NVAX | Novavax, Inc. | 1.41B | -1.98% | 1,974,987 | 1.12B |
| 320 | BFLY | Butterfly Network, Inc. | 1.40B | 1.10% | 4,174,404 | 97.61M |
| 321 | AVBP | ArriVent BioPharma, Inc. | 1.40B | 6.92% | 496,088 | - |
| 322 | KMTS | Kestra Medical Technologies, Ltd. | 1.38B | 3.73% | 245,912 | 83.72M |
| 323 | HCSG | Healthcare Services Group, Inc. | 1.36B | 0.68% | 259,303 | 1.84B |
| 324 | MAZE | Maze Therapeutics, Inc. | 1.35B | -3.52% | 423,420 | 2.50M |
| 325 | GHRS | GH Research PLC | 1.33B | 16.90% | 1,359,772 | - |
| 326 | CRVS | Corvus Pharmaceuticals, Inc. | 1.31B | -6.57% | 990,327 | - |
| 327 | MLTX | MoonLake Immunotherapeutics | 1.28B | -2.67% | 417,099 | - |
| 328 | DBVT | DBV Technologies S.A. | 1.27B | -1.59% | 282,820 | 5.64M |
| 329 | STAA | STAAR Surgical Company | 1.27B | 1.93% | 377,553 | 239.44M |
| 330 | ZBIO | Zenas BioPharma, Inc. | 1.26B | -2.75% | 206,669 | 10.00M |
| 331 | EYPT | EyePoint, Inc. | 1.26B | 0.80% | 638,945 | 31.37M |
| 332 | MPLT | MapLight Therapeutics, Inc. | 1.25B | -5.39% | 232,997 | - |
| 333 | PHAR | Pharming Group N.V. | 1.24B | 0.81% | 10,025 | 376.13M |
| 334 | CMPS | COMPASS Pathways plc | 1.22B | 42.49% | 37,869,902 | - |
| 335 | AZTA | Azenta, Inc. | 1.21B | 4.99% | 607,595 | 595.03M |
| 336 | SEPN | Septerna, Inc. | 1.21B | 2.87% | 528,242 | 45.95M |
| 337 | URGN | UroGen Pharma Ltd. | 1.20B | 9.80% | 1,006,814 | 109.79M |
| 338 | CNMD | CONMED Corporation | 1.20B | 2.03% | 293,155 | 1.37B |
| 339 | INBX | Inhibrx Biosciences, Inc. | 1.19B | -7.45% | 212,003 | 1.30M |
| 340 | ABCL | AbCellera Biologics Inc. | 1.19B | -2.12% | 4,881,989 | 75.13M |
| 341 | IRMD | IRADIMED CORPORATION | 1.19B | -1.01% | 70,119 | 83.81M |
| 342 | EVO | Evotec SE | 1.18B | -3.37% | 73,217 | 925.65M |
| 343 | IVA | Inventiva S.A. | 1.17B | -1.23% | 198,888 | 7.94M |
| 344 | NNNN | Anbio Biotechnology | 1.17B | -2.03% | 21,197 | 8.65M |
| 345 | CLOV | Clover Health Investments, Corp. | 1.17B | 1.60% | 2,788,578 | 1.92B |
| 346 | AKTS | Aktis Oncology, Inc. | 1.15B | 3.19% | 152,673 | 6.50M |
| 347 | JBIO | Jade Biosciences, Inc. | 1.15B | 2.19% | 387,201 | - |
| 348 | AVNS | Avanos Medical, Inc. | 1.15B | 0.04% | 680,705 | 701.20M |
| 349 | USPH | U.S. Physical Therapy, Inc. | 1.15B | -1.03% | 172,701 | 773.34M |
| 350 | QURE | uniQure N.V. | 1.14B | 2.67% | 1,844,769 | 16.10M |
| 351 | ALVO | Alvotech | 1.13B | 0.28% | 164,364 | 588.90M |
| 352 | COLL | Collegium Pharmaceutical, Inc. | 1.11B | -0.25% | 253,169 | 780.57M |
| 353 | TDOC | Teladoc Health, Inc. | 1.11B | 7.91% | 4,293,911 | 2.53B |
| 354 | CDNA | CareDx, Inc. | 1.09B | -0.70% | 396,501 | 379.81M |
| 355 | INNV | InnovAge Holding Corp. | 1.09B | -2.79% | 90,939 | 915.37M |
| 356 | ORIC | ORIC Pharmaceuticals, Inc. | 1.09B | 0.74% | 836,308 | - |
| 357 | XERS | Xeris Biopharma Holdings, Inc. | 1.08B | -1.73% | 1,131,745 | 291.85M |
| 358 | BLFS | BioLife Solutions, Inc. | 1.08B | 3.81% | 409,870 | 96.21M |
| 359 | NEO | NeoGenomics, Inc. | 1.07B | -1.50% | 1,516,300 | 727.33M |
| 360 | PHAT | Phathom Pharmaceuticals, Inc. | 1.07B | 1.97% | 559,562 | 175.11M |
| 361 | KALV | KalVista Pharmaceuticals, Inc. | 1.07B | 1.71% | 557,112 | 73.62M |
| 362 | SANA | Sana Biotechnology, Inc. | 1.06B | 9.38% | 4,537,475 | - |
| 363 | CTMX | CytomX Therapeutics, Inc. | 1.06B | 1.35% | 2,173,105 | 76.20M |
| 364 | PNTG | The Pennant Group, Inc. | 1.04B | -3.22% | 69,910 | 947.71M |
| 365 | ANNX | Annexon, Inc. | 1.03B | -2.14% | 1,020,864 | - |
| 366 | CRON | Cronos Group Inc. | 1.03B | 2.60% | 1,154,688 | 146.59M |
| 367 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.02B | 0.57% | 347,272 | 719.89M |
| 368 | PCRX | Pacira BioSciences, Inc. | 1.01B | 0.65% | 594,324 | 726.41M |
| 369 | GERN | Geron Corporation | 1.00B | -6.85% | 19,083,752 | 183.88M |
| 370 | EVMN | Evommune, Inc. | 999.15M | 1.06% | 291,680 | 13.00M |
| 371 | OMER | Omeros Corporation | 984.91M | 1.79% | 920,939 | - |
| 372 | FTRE | Fortrea Holdings Inc. | 978.01M | 0.77% | 360,317 | 2.72B |
| 373 | CMPX | Compass Therapeutics, Inc. | 977.88M | -9.50% | 2,386,030 | 850.00K |
| 374 | MGTX | MeiraGTx Holdings plc | 971.85M | 3.75% | 898,948 | 81.39M |
| 375 | SSII | SS Innovations International, Inc. | 971.71M | -0.61% | 38,835 | 42.48M |
| 376 | JANX | Janux Therapeutics, Inc. | 970.26M | 0.82% | 2,292,265 | 10.00M |
| 377 | CERT | Certara, Inc. | 949.08M | -0.48% | 1,179,192 | 418.84M |
| 378 | ANRO | Alto Neuroscience, Inc. | 947.48M | -2.49% | 258,195 | - |
| 379 | LMRI | Lumexa Imaging Holdings, Inc. | 943.32M | 1.60% | 919,748 | 1.02B |
| 380 | SDGR | Schrödinger, Inc. | 941.27M | 3.32% | 983,283 | 255.87M |
| 381 | XNCR | Xencor, Inc. | 940.93M | -1.76% | 507,603 | 125.58M |
| 382 | OPK | OPKO Health, Inc. | 929.86M | -1.21% | 926,049 | 606.88M |
| 383 | INMD | InMode Ltd. | 923.14M | -0.55% | 549,137 | 370.50M |
| 384 | MRVI | Maravai LifeSciences Holdings, Inc. | 922.87M | 5.90% | 2,052,708 | 185.74M |
| 385 | ABUS | Arbutus Biopharma Corporation | 907.89M | -2.33% | 646,010 | 14.08M |
| 386 | LBRX | LB Pharmaceuticals Inc | 903.83M | 3.28% | 160,238 | - |
| 387 | MNKD | MannKind Corporation | 900.14M | 2.64% | 2,744,873 | 348.97M |
| 388 | SLS | SELLAS Life Sciences Group, Inc. | 898.81M | -4.12% | 5,636,889 | - |
| 389 | CGEM | Cullinan Therapeutics, Inc. | 885.50M | -2.86% | 377,309 | - |
| 390 | DRUG | Bright Minds Biosciences Inc. | 884.14M | 0.22% | 65,024 | - |
| 391 | QDEL | QuidelOrtho Corporation | 874.85M | 1.10% | 2,887,888 | 2.73B |
| 392 | IART | Integra LifeSciences Holdings Corporation | 870.95M | 0.31% | 387,214 | 1.64B |
| 393 | TALK | Talkspace, Inc. | 866.29M | 0.10% | 611,186 | 228.87M |
| 394 | TBPH | Theravance Biopharma, Inc. | 865.60M | -2.44% | 304,200 | 107.46M |
| 395 | KURA | Kura Oncology, Inc. | 861.89M | 0.31% | 1,240,298 | 67.48M |
| 396 | BVS | Bioventus Inc. | 851.51M | -2.66% | 305,773 | 568.09M |
| 397 | VOR | Vor Biopharma Inc. | 848.55M | -5.61% | 962,830 | - |
| 398 | SLDB | Solid Biosciences Inc. | 839.31M | -1.16% | 602,738 | - |
| 399 | TLRY | Tilray Brands, Inc. | 838.00M | 5.10% | 4,535,663 | 858.28M |
| 400 | FBRX | Forte Biosciences, Inc. | 835.44M | 0.62% | 152,164 | - |
| 401 | ALLO | Allogene Therapeutics, Inc. | 834.15M | 1.46% | 10,714,541 | 22.00K |
| 402 | BIOA | BioAge Labs, Inc. | 831.23M | 1.30% | 494,248 | 9.00M |
| 403 | OMDA | Omada Health, Inc. | 829.08M | -0.50% | 340,766 | 260.21M |
| 404 | SGP | SpyGlass Pharma, Inc. | 821.62M | -1.44% | 18,595 | - |
| 405 | GDRX | GoodRx Holdings, Inc. | 815.33M | 4.85% | 1,111,649 | 796.85M |
| 406 | SPRY | ARS Pharmaceuticals, Inc. | 813.24M | 0.12% | 700,207 | 84.28M |
| 407 | DSGN | Design Therapeutics, Inc. | 811.61M | 0.30% | 120,843 | - |
| 408 | CBLL | CeriBell, Inc. | 790.09M | -0.94% | 128,519 | 89.06M |
| 409 | AMN | AMN Healthcare Services, Inc. | 788.20M | 0.99% | 293,576 | 2.73B |
| 410 | RLMD | Relmada Therapeutics, Inc. | 776.17M | -1.07% | 1,833,825 | - |
| 411 | LXRX | Lexicon Pharmaceuticals, Inc. | 775.34M | -2.14% | 1,518,270 | 49.80M |
| 412 | NUTX | Nutex Health Inc. | 766.24M | 4.15% | 125,344 | 875.26M |
| 413 | CSTL | Castle Biosciences, Inc. | 759.52M | 0.08% | 123,719 | 344.23M |
| 414 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 743.50M | -0.64% | 271,435 | - |
| 415 | GYRE | Gyre Therapeutics, Inc. | 724.12M | -2.10% | 41,445 | 116.59M |
| 416 | CBIO | Crescent Biopharma, Inc. | 724.06M | 2.44% | 125,495 | 10.84M |
| 417 | IRWD | Ironwood Pharmaceuticals, Inc. | 722.35M | - | 810,559 | 296.15M |
| 418 | TENX | Tenax Therapeutics, Inc. | 716.28M | -1.45% | 308,832 | - |
| 419 | DRTS | Alpha Tau Medical Ltd. | 711.99M | 0.75% | 223,988 | - |
| 420 | EHAB | Enhabit, Inc. | 695.92M | - | 351,592 | 1.06B |
| 421 | ETON | Eton Pharmaceuticals, Inc. | 692.75M | 1.40% | 229,846 | 79.95M |
| 422 | PRME | Prime Medicine, Inc. | 691.50M | 2.49% | 842,478 | 4.63M |
| 423 | ARVN | Arvinas, Inc. | 688.22M | -2.18% | 354,878 | 262.60M |
| 424 | KYTX | Kyverna Therapeutics, Inc. | 677.94M | 12.79% | 2,450,781 | - |
| 425 | PSNL | Personalis, Inc. | 662.61M | -5.94% | 2,603,326 | 69.65M |
| 426 | ANL | Adlai Nortye Ltd. | 658.40M | 2.81% | 654,097 | 5.00M |
| 427 | BWAY | BrainsWay Ltd. | 648.57M | -1.20% | 105,341 | 52.23M |
| 428 | PROK | ProKidney Corp. | 637.04M | -3.21% | 577,258 | 893.00K |
| 429 | ZVRA | Zevra Therapeutics, Inc. | 634.09M | 1.22% | 430,303 | 106.47M |
| 430 | EIKN | Eikon Therapeutics, Inc. | 631.80M | -1.93% | 124,581 | - |
| 431 | SIBN | SI-BONE, Inc. | 631.12M | 1.42% | 260,697 | 200.93M |
| 432 | HSTM | HealthStream, Inc. | 628.23M | -1.52% | 93,327 | 304.06M |
| 433 | OCGN | Ocugen, Inc. | 626.80M | -6.78% | 10,886,449 | 4.41M |
| 434 | ABSI | Absci Corporation | 605.96M | 10.61% | 5,158,318 | 2.80M |
| 435 | CRMD | CorMedix Inc. | 603.55M | 3.32% | 827,853 | 311.71M |
| 436 | STTK | Shattuck Labs, Inc. | 602.39M | 5.84% | 939,360 | 1.00M |
| 437 | RIGL | Rigel Pharmaceuticals, Inc. | 600.38M | 0.22% | 163,461 | 294.28M |
| 438 | ACRS | Aclaris Therapeutics, Inc. | 594.20M | 0.59% | 911,406 | 7.83M |
| 439 | CTKB | Cytek Biosciences, Inc. | 586.83M | -0.98% | 279,196 | 201.49M |
| 440 | PRTA | Prothena Corporation plc | 585.70M | -0.18% | 235,044 | 9.68M |
| 441 | AVR | Anteris Technologies Global Corp. | 579.05M | -2.14% | 349,691 | 1.91M |
| 442 | TCMD | Tactile Systems Technology, Inc. | 578.77M | -1.13% | 77,464 | 329.52M |
| 443 | LYEL | Lyell Immunopharma, Inc. | 573.65M | 2.42% | 107,628 | 36.00K |
| 444 | PHR | Phreesia, Inc. | 571.78M | 2.62% | 921,384 | 480.59M |
| 445 | VSTM | Verastem, Inc. | 570.98M | -1.22% | 1,597,908 | 30.91M |
| 446 | BBNX | Beta Bionics, Inc. | 570.84M | -1.31% | 955,744 | 100.25M |
| 447 | EMBC | Embecta Corp. | 569.69M | -1.64% | 589,943 | 1.08B |
| 448 | STRO | Sutro Biopharma, Inc. | 566.19M | 8.32% | 173,138 | 102.48M |
| 449 | ENGN | enGene Therapeutics Inc. | 562.71M | 4.09% | 361,854 | - |
| 450 | NPCE | NeuroPace, Inc. | 556.18M | 2.04% | 96,442 | 99.99M |
| 451 | UPB | Upstream Bio, Inc. | 544.20M | 0.10% | 279,814 | 2.85M |
| 452 | ADCT | ADC Therapeutics SA | 541.21M | -0.47% | 523,932 | 81.36M |
| 453 | TECX | Tectonic Therapeutic, Inc. | 539.55M | -2.63% | 181,928 | - |
| 454 | IMMX | Immix Biopharma, Inc. | 537.01M | -2.13% | 481,694 | - |
| 455 | VALN | Valneva SE | 535.43M | 1.68% | 249,962 | 205.07M |
| 456 | FULC | Fulcrum Therapeutics, Inc. | 528.14M | -4.34% | 442,637 | 80.00M |
| 457 | CADL | Candel Therapeutics, Inc. | 527.74M | 13.11% | 5,034,029 | - |
| 458 | PACB | Pacific Biosciences of California, Inc. | 525.48M | 2.96% | 3,367,808 | 160.01M |
| 459 | AGMB | AgomAb Therapeutics NV | 524.41M | -5.03% | 327,061 | - |
| 460 | CATX | Perspective Therapeutics, Inc. | 522.95M | 9.29% | 1,780,324 | 884.00K |
| 461 | ZURA | Zura Bio Limited | 517.10M | -6.20% | 934,376 | - |
| 462 | AQST | Aquestive Therapeutics, Inc. | 516.25M | -2.08% | 1,574,544 | 44.55M |
| 463 | FDMT | 4D Molecular Therapeutics, Inc. | 515.11M | -3.81% | 369,917 | 85.21M |
| 464 | ESPR | Esperion Therapeutics, Inc. | 513.62M | -1.96% | 4,665,347 | 403.14M |
| 465 | OFIX | Orthofix Medical Inc. | 507.43M | -0.55% | 108,682 | 822.31M |
| 466 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 467 | VREX | Varex Imaging Corporation | 500.94M | -0.50% | 93,889 | 854.40M |
| 468 | LRMR | Larimar Therapeutics, Inc. | 500.20M | 0.31% | 703,547 | - |
| 469 | CTNM | Contineum Therapeutics, Inc. | 497.50M | -1.52% | 290,856 | - |
| 470 | TRDA | Entrada Therapeutics, Inc. | 493.20M | -2.07% | 65,292 | 25.42M |
| 471 | RGNX | REGENXBIO Inc. | 489.33M | -0.11% | 556,425 | 170.44M |
| 472 | KMDA | Kamada Ltd. | 486.21M | -2.41% | 27,810 | 180.46M |
| 473 | LXEO | Lexeo Therapeutics, Inc. | 484.53M | -5.35% | 590,404 | - |
| 474 | MDXG | MiMedx Group, Inc. | 484.33M | -4.54% | 2,055,958 | 418.63M |
| 475 | MYGN | Myriad Genetics, Inc. | 484.02M | 0.89% | 426,893 | 824.50M |
| 476 | BNTC | Benitec Biopharma Inc. | 481.62M | -0.14% | 62,583 | - |
| 477 | IVVD | Invivyd, Inc. | 479.35M | -2.59% | 1,280,741 | 53.43M |
| 478 | XOMA | XOMA Royalty Corporation | 475.80M | 0.55% | 82,442 | 52.15M |
| 479 | VTVT | vTv Therapeutics Inc. | 468.15M | -1.04% | 26,869 | 17.00K |
| 480 | ARMP | Armata Pharmaceuticals, Inc. | 464.87M | 10.35% | 78,184 | 4.90M |
| 481 | AGL | agilon health, inc. | 464.49M | -6.86% | 561,437 | 5.93B |
| 482 | ALT | Altimmune, Inc. | 464.48M | 2.00% | 1,798,069 | 41.00K |
| 483 | FLGT | Fulgent Genetics, Inc. | 463.24M | -1.23% | 202,757 | 322.67M |
| 484 | DNA | Ginkgo Bioworks Holdings, Inc. | 460.42M | -1.49% | 797,469 | 170.16M |
| 485 | AVIR | Atea Pharmaceuticals, Inc. | 455.33M | -0.44% | 133,736 | - |
| 486 | ANGO | AngioDynamics, Inc. | 451.42M | -0.28% | 312,860 | 313.73M |
| 487 | AURA | Aura Biosciences, Inc. | 450.98M | -3.57% | 243,873 | - |
| 488 | ASMB | Assembly Biosciences, Inc. | 443.52M | -4.38% | 79,522 | 72.30M |
| 489 | EPRX | Eupraxia Pharmaceuticals Inc. | 438.18M | 2.39% | 141,958 | - |
| 490 | CGC | Canopy Growth Corporation | 437.34M | 5.26% | 14,316,822 | 203.04M |
| 491 | PRTC | PureTech Health plc | 436.98M | 0.33% | 837 | 6.39M |
| 492 | CLYM | Climb Bio, Inc. | 432.78M | -1.09% | 248,147 | - |
| 493 | EBS | Emergent BioSolutions Inc. | 430.72M | -5.33% | 414,780 | 742.90M |
| 494 | NGNE | Neurogene Inc. | 430.32M | -0.79% | 121,658 | 925.00K |
| 495 | WEAV | Weave Communications, Inc. | 429.81M | 2.53% | 484,307 | 239.02M |
| 496 | RCKT | Rocket Pharmaceuticals, Inc. | 424.49M | -0.51% | 1,429,887 | - |
| 497 | CYH | Community Health Systems, Inc. | 423.68M | 0.16% | 1,333,078 | 12.49B |
| 498 | AUTL | Autolus Therapeutics plc | 421.84M | -0.94% | 791,589 | 75.39M |
| 499 | IPSC | Century Therapeutics, Inc. | 421.45M | -9.81% | 1,061,133 | 109.16M |
| 500 | KIDS | OrthoPediatrics Corp. | 421.14M | -0.54% | 97,091 | 236.35M |